Surgery – Diagnostic testing – Detecting brain electric signal
Reexamination Certificate
2007-06-12
2007-06-12
Hindenburg, Max (Department: 3735)
Surgery
Diagnostic testing
Detecting brain electric signal
Reexamination Certificate
active
10337088
ABSTRACT:
The present invention is a system and method that produces features and indices that indicate the presence or absence of a disease or condition, or of the progression of a disease or condition. The system and method of the present invention also produce features and indices that predict responsiveness to medication from a premedication baseline. The system and method of the present invention further incorporates a testing methodology to improve the performance characteristics of the features or indices. To obtain such features and indices, time domain, power spectrum, bispectrum and higher order spectrum values are derived from biopotential signals taken from the subject being tested.
REFERENCES:
patent: 4533346 (1985-08-01), Cosgrove et al.
patent: 4907597 (1990-03-01), Chamoun
patent: 5010891 (1991-04-01), Chamoun
patent: 5230346 (1993-07-01), Leuchter et al.
patent: 5269315 (1993-12-01), Leuchter et al.
patent: 5309923 (1994-05-01), Leuchter et al.
patent: 5311876 (1994-05-01), Olsen
patent: 5320109 (1994-06-01), Chamoun et al.
patent: 5458117 (1995-10-01), Chamoun et al.
patent: 5846208 (1998-12-01), Pichlmayr
patent: 6024707 (2000-02-01), Scinto et al.
patent: 6343229 (2002-01-01), Siebler
patent: 6622036 (2003-09-01), Suffin
Alkire, Michael T., “Quantitative EEG Correlations with Brain Glucose Metabolic Rate during Anesthesia In Volunteers,” Anesthesiology 1998, vol. 89, pp. 323-333.
Besthorn, C., et al., “Discrimination of Alzheimer's Disease and Normal Aging by EEG Data,” Electroencephalography and Clinical Neurophysiology 1997, vol. 103, pp. 241-248.
Claus, J.J., et al., “The Diagnostic Value of Electroencephalography in Mild Senile Alzheimer's Disease,” Clinical Neurophysiology 1999, vol. 110, pp. 825-832.
Coben, L.A., et al, “A Longitudinal EEG Study of Mild Senile Dementia of Alzheimer Type: Changes at 1 Year and at 2.5 Years,” Electroencephalogr. Clin. Neurophysiol. 1985, vol. 2, pp. 101-112.
Cook, Ian A., et al, “Prefrontal Changes and Treatment Response Prediction in Depression,” Seminars in Clinical Neuropsychiatry, 2001, vol. 6, pp. 113-120.
Diego, Niguel, A., et al., “CES-D Depression Scores are Correlated with Frontal EEG Alpha Asymmetry,” Depression and Anxiety 2001, vol. 13, pp. 32-37.
Folstein, Marshall F., et al “Mini-Mental State” “A Practical Method for Grading the Cognitive State of Patients for the Clinican,” J. Psychiat res. 1975, vol. 12, pp. 189-198.
Glass, Peter S., et al., “Bispectral Analysis Measures Sedation and Memory Effects of Propofol, Midazolam, Isoflurane, and Alfentanil in Health Volunteers,” Anesthesiology, 1997, vol. 86, pp. 836-847.
Hamilton, Max, “A Rating Scale for Depression,” J. Neurol. Neurosurg. Psychiat., 1960, vol. 23, pp. 56-62.
Hassainia, F., et al. “Quantitative EEG and Statistical Mapping of Wakefulness and REM Sleep in the Evaluation of Mild to Moderate Alzheimer's Disease,” Eur. Neurol. 1997, vol. 37, pp. 219-224.
Holschneider, Daniel P., et al., “Loss of High-Frequency Brain Electrical Response to Thipental Administration in Alzheimer's-Type Dementia,” Neurophychopharmacology 1997, vol. 16, pp. 26-275.
Jonkman, E.J., “The Role of the Electroencephalogram in the Diagnosis of Dementia of the Alzheimer Type: an Attempt at Technology Assessment,” Neurophysiol. Clin. 1997, vol. 27, pp. 211-219.
Knott, Verner J., “Quantitive EEG in the Prediction of Antidepressant Response to Imipramine,” J. Affective Disorders, 1996, vol. 39, pp. 175-184.
Knott, V., et al., “Pre-Treatment EEG at It's Relationship to Depression Severity and Paroxetine Treatment Outcome,” Pharmacopsychiatry 2000, vol. 33, pp. 201-205.
Leuchter, Andrew F., “Regional Differences in Brain Electrical Activity in Dementia: Use of Spectral Power and Spectral Ratio Measures,” Electroencephalography and Clinical Neurophysiology, 1993, vol. 87, pp. 385-393.
McKhann, Guy, et al., “Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease,” Neurology, 1984, vol. 34, pp. 939-944.
Neufeld, M.Y., “Effects of a Single Intravenous Dose of Scopolamine on the Quantitative EEG in Alzheimer's Disease Patents and Age-Matched Controls,” Electroencephalography and Clin. Neurophysiology, 1994, vol. 91, pp. 407-412.
Pezard, Laurent, “Entropy Maps Characterizer Drug Effects on Brain Dynamics in Alzheimer's Disease,” Neuroscience Letters, 1998, vol. 253, pp. 5-8.
Rampil, Ira J., A Primer for EEG Signal Processing in Anesthesia, Anesthesiology, 1998, vol. 89, pp. 980-1002.
Renna, Maurizio, “Does Dementia Affect the Bispectal Index?” Amer. Society of Anesthesiologists, 2001, p. 1 of 2.
Struys, M.D., Michel, RUGLOOP Software, University of Gent, Department of Anaesthesia, Belgium.
Devlin Philip H.
Greenwald Scott D.
Sigl Jeffrey C.
Smith Charles P.
Aspect Medical Systems, Inc.
Hindenburg Max
Natnithithadha Navin
LandOfFree
System and method of assessment of neurological conditions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method of assessment of neurological conditions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method of assessment of neurological conditions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3846493